These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27463022)

  • 1. CYP2D6 ultra-rapid metabolizer phenotype not associated with attempted suicide in a large sample of psychiatric inpatients.
    Stephens DB; de Leon J
    Pharmacogenomics; 2016 Aug; 17(12):1295-304. PubMed ID: 27463022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2D6 polymorphism and mental and personality disorders in suicide attempters.
    Blasco-Fontecilla H; Peñas-Lledó E; Vaquero-Lorenzo C; Dorado P; Saiz-Ruiz J; Llerena A; Baca-García E
    J Pers Disord; 2014 Dec; 28(6):873-83. PubMed ID: 25437930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice.
    Mulder H; Herder A; Wilmink FW; Tamminga WJ; Belitser SV; Egberts AC
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):107-14. PubMed ID: 16294366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances.
    Peñas-Lledó E; Guillaume S; Naranjo ME; Delgado A; Jaussent I; Blasco-Fontecilla H; Courtet P; LLerena A
    Pharmacogenomics J; 2015 Apr; 15(2):172-6. PubMed ID: 25113522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 2D6 phenoconversion is common in patients being treated for depression: implications for personalized medicine.
    Preskorn SH; Kane CP; Lobello K; Nichols AI; Fayyad R; Buckley G; Focht K; Guico-Pabia CJ
    J Clin Psychiatry; 2013 Jun; 74(6):614-21. PubMed ID: 23541126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
    Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
    Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy.
    Antunes MV; Linden R; Santos TV; Wallemacq P; Haufroid V; Classen JF; Andreolla H; Costa N; Fontanive TO; Rosa DD
    Ther Drug Monit; 2012 Aug; 34(4):422-31. PubMed ID: 22777153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of risperidone and aripiprazole in subgroups encoding CYP2D6 intermediate metabolizer phenotype.
    Hendset M; Molden E; Knape M; Hermann M
    Ther Drug Monit; 2014 Feb; 36(1):80-5. PubMed ID: 24232129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes in the CYP2D6 gene are related to severity of suicide attempt: A cross-sectional study of suicide attempters.
    Boström AED; Jamshidi E; Manu DM; Kular L; Schiöth HB; Åsberg M; Jokinen J
    J Psychiatr Res; 2023 Apr; 160():217-224. PubMed ID: 36857986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
    Linares OA; Fudin J; Daly AL; Boston RC
    Clin J Pain; 2015 Dec; 31(12):1026-35. PubMed ID: 25621429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.
    Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C
    Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital.
    de Leon J; Barnhill J; Rogers T; Boyle J; Chou WH; Wedlund PJ
    Am J Psychiatry; 1998 Sep; 155(9):1278-80. PubMed ID: 9734555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
    Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
    Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side effects associated with ultrarapid cytochrome P450 2D6 genotype among women with early stage breast cancer treated with tamoxifen.
    Rolla R; Vidali M; Meola S; Pollarolo P; Fanello MR; Nicolotti C; Saggia C; Forti L; Agostino FD; Rossi V; Borra G; Stratica F; Alabiso O; Bellomo G
    Clin Lab; 2012; 58(11-12):1211-8. PubMed ID: 23289191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study.
    Tamminga WJ; Wemer J; Oosterhuis B; de Boer A; Vranckx S; Drenth BF; de Zeeuw RA; de Leij LF; Jonkman JH
    Eur J Clin Pharmacol; 2003 May; 59(1):57-64. PubMed ID: 12743673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism.
    Dorado P; González I; Naranjo ME; de Andrés F; Peñas-Lledó EM; Calzadilla LR; LLerena A
    OMICS; 2017 Jan; 21(1):17-26. PubMed ID: 28271978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical excitation on diphenhydramine may be associated with being a CYP2D6 ultrarapid metabolizer: three case reports.
    de Leon J; Nikoloff DM
    CNS Spectr; 2008 Feb; 13(2):133-5. PubMed ID: 18227744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextromethorphan-induced near-fatal suicide attempt in a slow metabolizer at cytochrome P450 2D6.
    Matin N; Kurani A; Kennedy CA; Liu QY
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):162-5. PubMed ID: 17719518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A socio-demographic, psychiatric and medical profile of inpatient suicide attempters in a psychiatric hospital of Puerto Rico.
    Martínez GL; Herrero R; Fabelo C; Diaz D; McCarthy V
    Bol Asoc Med P R; 2009; 101(1):23-30. PubMed ID: 19954083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study.
    Thiele LS; Ishtiak-Ahmed K; Thirstrup JP; Agerbo E; Lunenburg CATC; Müller DJ; Gasse C
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.